High Efficacy of Ivermectin for Strongyloidiasis Treatment

Chatchawan Sengthong,Somchai Pinlaor,Manachai Yingklang,Ornuma Haonon,Chanakan Jantawong,Porntip Pinlaor,Paiboon Sithithaworn,Nuttanan Hongsrichan
DOI: https://doi.org/10.4269/ajtmh.23-0645
2024-04-02
Abstract:Infection with Strongyloides stercoralis is often asymptomatic but can be life-threatening in immunocompromised patients, which can be prevented by ivermectin (IVM) treatment. The efficacy of IVM has been reported to have lessened over time in some regions as a consequence of prolonged use and mass treatment campaigns. Ivermectin has been used in Thailand for more than a decade; therefore, we investigated the efficacy of a single dose (200 μg/kg) of IVM against in asymptomatic strongyloidiasis in northeastern Thailand. Fecal samples were collected before and 2 weeks after treatment and were analyzed for the presence of Strongyloides using a modified agar plate culture and the formalin-ethyl acetate concentration technique. Our results showed that single-dose IVM treatment successfully eliminated S. stercoralis infection in asymptomatic individuals in the endemic area with a 100% cure rate, indicating the high efficacy of IVM treatment in strongyloidiasis in northeast Thailand.
public, environmental & occupational health,tropical medicine
What problem does this paper attempt to address?